Home › Juvenile Myelomonocytic Leukemia › Washington
Juvenile Myelomonocytic Leukemia clinical trials in Washington
3 studies for Juvenile Myelomonocytic Leukemia are looking for participants at sites in Washington.
Cities in Washington
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
- Seattle Children's Hospital, Seattle
RecruitingPhase 1/2
1 Month – 21 Years · All sexes · Updated Sep 4, 2026 · NCT05849662The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Seattle Children's Hospital, Seattle
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
- Mary Bridge Children's Hospital and Health Center, Tacoma
- and 1 more
RecruitingPhase 1/2
Up to age 22 · All sexes · Updated Aug 25, 2026 · NCT04726241HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
- Fred Hutch/University of Washington Cancer Consortium, Seattle
RecruitingPhase 1
Up to age 80 · All sexes · Updated May 18, 2026 · NCT03326921From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.